STAT3 and neoplasm: More recently, it was shown that membrane-associated Hsp72 from tumor exosomes activates STAT3 in MDSCs through a TLR2/Myeloid differentiation primary response 88 (MYD88)-dependent pathway mediated by the autocrine production of IL-6 (53).